Whitnell & Co. Has $3.54 Million Stock Position in CVS Health Corp (NYSE:CVS)

Whitnell & Co. raised its position in shares of CVS Health Corp (NYSE:CVS) by 8.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,091 shares of the pharmacy operator’s stock after purchasing an additional 4,546 shares during the period. CVS Health makes up approximately 1.2% of Whitnell & Co.’s investment portfolio, making the stock its 28th biggest position. Whitnell & Co.’s holdings in CVS Health were worth $3,538,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of CVS. 1 North Wealth Services LLC bought a new stake in shares of CVS Health during the third quarter worth $29,000. Centaurus Financial Inc. grew its stake in shares of CVS Health by 570.8% in the first quarter. Centaurus Financial Inc. now owns 1,630 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,387 shares during the last quarter. Manchester Financial Inc. bought a new stake in shares of CVS Health in the second quarter worth $31,000. Hudock Capital Group LLC grew its stake in shares of CVS Health by 54.0% in the second quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 202 shares during the last quarter. Finally, Executive Wealth Management LLC grew its stake in shares of CVS Health by 62.4% in the second quarter. Executive Wealth Management LLC now owns 565 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 217 shares during the last quarter. 76.17% of the stock is currently owned by hedge funds and other institutional investors.

In other CVS Health news, EVP Joshua Matthew Flum sold 17,703 shares of the stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $63.00, for a total value of $1,115,289.00. Following the completion of the sale, the executive vice president now owns 36,163 shares in the company, valued at approximately $2,278,269. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Troyen A. Brennan sold 23,604 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $68.00, for a total transaction of $1,605,072.00. Following the completion of the sale, the executive vice president now owns 107,921 shares of the company’s stock, valued at approximately $7,338,628. The disclosure for this sale can be found here. Insiders sold a total of 49,437 shares of company stock worth $3,248,811 in the last 90 days. 0.53% of the stock is currently owned by company insiders.

Several analysts recently weighed in on CVS shares. ValuEngine raised shares of CVS Health from a “strong sell” rating to a “sell” rating in a research note on Wednesday, October 2nd. UBS Group reissued a “buy” rating and issued a $78.00 price objective on shares of CVS Health in a research note on Thursday. Royal Bank of Canada started coverage on shares of CVS Health in a research note on Friday, September 27th. They issued an “outperform” rating and a $85.00 price objective on the stock. Citigroup boosted their price objective on shares of CVS Health from $72.00 to $83.00 and gave the stock a “buy” rating in a research note on Thursday. They noted that the move was a valuation call. Finally, SunTrust Banks boosted their price objective on shares of CVS Health to $85.00 and gave the stock a “buy” rating in a research note on Thursday. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $77.59.

Shares of NYSE CVS traded up $0.69 during trading on Friday, hitting $72.47. 9,079,719 shares of the company traded hands, compared to its average volume of 6,966,567. The business’s fifty day moving average is $64.66 and its 200 day moving average is $58.54. CVS Health Corp has a fifty-two week low of $51.72 and a fifty-two week high of $82.15. The firm has a market capitalization of $87.55 billion, a price-to-earnings ratio of 10.24, a P/E/G ratio of 1.46 and a beta of 0.86. The company has a debt-to-equity ratio of 1.39, a quick ratio of 0.64 and a current ratio of 0.95.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.77 by $0.07. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The firm had revenue of $64.81 billion for the quarter, compared to analyst estimates of $62.99 billion. During the same quarter in the prior year, the business earned $1.73 earnings per share. The business’s quarterly revenue was up 36.5% compared to the same quarter last year. On average, analysts predict that CVS Health Corp will post 6.99 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Monday, November 4th. Investors of record on Thursday, October 24th were issued a $0.50 dividend. The ex-dividend date was Wednesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.76%. CVS Health’s dividend payout ratio is presently 28.25%.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Featured Story: Rule of 72

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.